title: Epithelial-stromal tumor of the seminal vesicles in the transgenic adenocarcinoma mouse prostate model.
abstract: The transgenic adenocarcinoma mouse prostate (TRAMP) model, designed for researching human prostatic cancer, was genetically engineered to harbor a transgene composed of the simian virus 40 Large-T/small-t antigen promoted by the rat probasin gene. In addition to prostatic neoplasms, the TRAMP mouse develops tumors in the seminal vesicles. This study was conducted to evaluate the pathology and histogenesis of TRAMP seminal vesicle neoplasms. Tissues of accessory sex organs harvested from 72 TRAMP mice of various ages (11-40 weeks of age) were fixed in neutral buffered formalin and stained with hematoxylin and eosin, desmin, 5-bromo-2'-deoxyuridine (BrdU, treated animals only), and SV40 Large-T antigen (SV40-Tag). In the seminal vesicles, we found neoplastic stromal cells that emerged multicentrically just beneath the epithelium, densely packed between the epithelium and the smooth muscle layer. These stromal cells frequently exhibited mitotic figures and showed BrdU incorporation and SV40-Tag protein expression in the nuclei and immunopositivity for desmin. The proliferative mesenchymal cells were lined by cuboidal to columnar epithelium. Some of the larger papillary, polypoid lesions exhibited a phyllodes pattern resembling that seen in mixed epithelial-stromal tumors of the breast, prostate, and seminal vesicles of humans. Although the epithelium was negative for SV40-Tag and showed only occasional incorporation of BrdU, it clearly participated in the biphasic proliferation, forming papillary, cystic, and tubuloglandular structures. No conclusive evidence of malignancy (invasion or metastasis) was identified. Our recommended diagnosis of this lesion in the seminal vesicles is epithelial-stromal tumor.
authors.affiliation: Laboratory of Experimental Pathology, National Institute of Environmental Health Sciences, PO Box 12233, Mail Drop B3-06, Research Triangle Park, NC 27709, USA.
authors.forename: Y
authors.initials: Y
authors.lastname: Tani
authors.forename: A
authors.initials: A
authors.lastname: Suttie
authors.forename: G P
authors.initials: GP
authors.lastname: Flake
authors.forename: A
authors.initials: A
authors.lastname: Nyska
authors.forename: R R
authors.initials: RR
authors.lastname: Maronpot
mesh_terms: D000818:Animals; D000952:Antigens, Polyomavirus Transforming / Q000378:metabolism; D001973:Bromodeoxyuridine; D002277:Carcinoma / Q000175:diagnosis / Q000473:pathology*; D003893:Desmin / Q000276:immunology; D005834:Genital Neoplasms, Male / Q000175:diagnosis / Q000473:pathology*; D007150:Immunohistochemistry; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D012669:Seminal Vesicles / Q000166:cytology / Q000473:pathology*; D017154:Stromal Cells / Q000473:pathology
chemical_list: D000952:Antigens, Polyomavirus Transforming; D003893:Desmin; D001973:Bromodeoxyuridine